AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2020
Apr 14, 2020
31676_dirs_2020-04-14_932f767a-e0d0-4b91-82b6-ce91f8a2b3d5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2020-04-10
Reporting Person: Marken James G. (SVP Ops & Prod Dev)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-04-10 | Common Stock | A | 24548 | — | Acquired | 85297 | Direct |
Footnotes
F1: The restricted stock vests in four equal annual installments on the first, second, third and fourth anniversaries of April 10, 2020.
More from ANI PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3